Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(14%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
29%
Ph phase_3
1
14%
Ph phase_2
1
14%
Ph phase_1
1
14%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(6)

Detailed Status

Completed6
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
N/A2 (40.0%)

Trials by Status

recruiting114%
completed686%

Recent Activity

1 active trials
Showing 5 of 7
completednot_applicable

Fractionated Stereotactic Radiotherapy for Limited Small Volume Brain Metastases

NCT07405047
recruitingphase_3

Fractionated Stereotactic Radiotherapy vs. Single Session Radiosurgery in Patients With Larger Brain Metastases

NCT03697343
completed

FSRT Combined With TMZ for Large BMs: a PSM Study

NCT03338075
completednot_applicable

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours

NCT00351962
completedphase_2

Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases

NCT02654106
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07405047Not Applicable

Fractionated Stereotactic Radiotherapy for Limited Small Volume Brain Metastases

Completed
NCT03697343Phase 3

Fractionated Stereotactic Radiotherapy vs. Single Session Radiosurgery in Patients With Larger Brain Metastases

Recruiting
NCT03338075

FSRT Combined With TMZ for Large BMs: a PSM Study

Completed
NCT00351962Not Applicable

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours

Completed
NCT02654106Phase 2

Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases

Completed
NCT00934271

Fractionated Stereotactic Radiotherapy in Patients With Acromegaly

Completed
NCT00822887Phase 1

Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas

Completed

All 7 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
7